Newsbenzinga
Milestone Pharmaceuticals Says China’s National Medical Products Administration Approves Etripamil Nasal Spray For Treatment Of Paroxysmal Supraventricular Tachycardia In Adults
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…